AVADEL PHARMACEUTICALS PLC (NASDAQ:AVDL) Files An 8-K Other EventsItem 8.01Other Events.
On March 27, 2018, the Board of Directors of Avadel Pharmaceuticals plc (the "Company") authorized a share repurchase program of up to $7 million of the Company's ordinary shares, represented by American Depositary Shares (ADSs) which are listed for trading on the NASDAQ Global Market. Repurchase may be made until December 31, 2018 in open-market transactions, block transactions on or off the exchange, in privately negotiated transactions, or through other means as determined by the Company's management and in accordance with the regulations of the Securities and Exchange Commission.
The timing and actual number of ADSs repurchased will depend on a variety of factors including price, trading volume, corporate, regulatory and legal requirements and market conditions. Repurchases may also be made under a trading plan under Rule 10b5-1 of the Securities and Exchange Act of 1934, which would permit ADSs to be repurchased during periods when repurchases would otherwise be prohibited due to self-imposed trading blackouts or other regulatory restrictions. The repurchase program may be suspended or discontinued at any time without notice.